Adding abiraterone to androgen deprivation therapy in men with metastatic hormone-sensitive prostate cancer: A systematic review and meta-analysis (2017)

First Author: Rydzewska L
Attributed to:  CANCER: Trials with potential global reach and other challenging trials funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.ejca.2017.07.003

PubMed Identifier: 28800492

Publication URI: http://europepmc.org/abstract/MED/28800492

Type: Journal Article/Review

Parent Publication: European Journal of Cancer

ISSN: 0959-8049